The report published by VynZ Research envisages the Global Autoinjectors Market to hit USD 5.5 billion by 2027, registering a CAGR of 17.4% during 2021-2027.
Due to the prevalence of chronic and lifestyle-related diseases, the increasing incidence of anaphylaxis, and the development in technology, the market is rising at a considerable pace.
Due to the benefits of disposable autoinjectors, such as handiness, less likelihood of contamination, and ease of use, the industry has seen strong demand for disposable autoinjectors in the coming years.
Get a Free Sample Copy of this Research Report at https://www.vynzresearch.com/healthcare/autoinjectors-market/request-sample
The Covid-19 outbreak is wreaking havoc on society and the global economy, disrupting the supply chain. The COVID-19 situation is causing uncertainty in the stock market, a major slowdown in supply chains, a drop in corporate confidence, and an increase in panic among customer segments. The report examines and analyses the impact of COVID-19 crisis on the Global Autoinjectors Market, providing in-depth analysis and expert recommendations on how to deal with the post COVID-19 period.
- By Product
- By Type
- By Design
- By Application
- Multiple sclerosis
- Rheumatoid arthritis
- By End-User
- Homecare Setting
- Hospitals and Clinics
The key growth factors for the market of autoinjectors are the growing prevalence of chronic and lifestyle-related illnesses, increasing number of regulatory approvals, technology improvement and design development, increasing medical attention and patient propensity to self-administration, mounting self-medication practices, and promising reimbursements and government support.
The growth of the market for autoinjectors is also facilitated by the patent expiry of biologics, novel formulations and revolutionary drug delivery systems, coupled with the discovery and improvement of biological drugs, increased healthcare spending, increased incidence of anaphylaxis and accessibility of generic varieties of autoinjectors.
Ask for Customization at: https://www.vynzresearch.com/healthcare/autoinjectors-market/customize-report
The key players in the Autoinjectors market:
- Mylan N.V.
- Johnson & Johnson
- Becton, Dickinson and Company
- Ypsomed AG
- Consort Medical Plc
- Eli Lilly and Company
- AbbVie Inc.
- Amgen Inc.
- Owen Mumford Ltd
- Scandinavian Health Limited
- Antares Pharma Inc.
- Wilhelm Haselmeier GmbH & Co. KG
The report also covers the market's major strategic developments, such as R&D, M&A, agreements, novel product launches, collaborations, partnerships, joint ventures, and regional growth of the market's competing firms on a global and regional scale.
Furthermore, the study includes Porter's five forces analysis of the industry to understand the impact of various factors on the growth of the Autoinjectors Market, such as bargaining power of suppliers, rivalry among competitors, the threat of new entrants, threat of substitutes products or service, and bargaining power of supplier.
About VynZ Research
VynZ Research is a market research firm offering research, analytics, and consulting services on business strategies. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies. VynZ Research assists enterprises to take strategic decisions for helping their businesses to grow. The reports developed by VynZ are based on market facts that include comprehensive analysis and quantification of market drivers, industry dynamics, opportunities, challenges, threats, market shares, and anticipated new trends & technologies arising across a wide range of industries.
Toll-Free (U.S. and Canada): +1-888-253-3960
Email: email@example.comTags:Extended Distribution, Research Newswire, English